Video26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #7 An Enzymatic Assay for Rapid and Minimally Instrumented Ganciclovir Triphosphate Monitoring in Infants With Congenital Cytomegalovirus - Willow ChernoskeView Video
Video26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #6 Target Attainment of Valganciclovir Prophylaxis against Cytomegalovirus - Suzanne WenkerView Video
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #5 Plasma Bictegravir/Emtricitabine/Tenofovir Alafenamide Concentrations in Transgender Women with HIV on Estrogen-Based Gender-Affirming Hormone Therapy in Comparison to Cisgender Women Living with HIV - Shawnalyn SunagawaView Video
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #4 Pharmacokinetic Parameters of Bictegravir in Breastmilk of Healthy, Lactating Volunteers without HIV After a Single Dose of 50mg (Co-Formulated with Emtricitabine 200mg and Tenofovir Alafenamide 25mg) - Lena Christina Wendy van der Wekken-PasView Video
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #3 Therapeutic Drug Monitoring of Dolutegravir in Children and Adolescents Living with HIV: A Retrospective Study - Émilie PiloteView Video
AOAdeniyi OlagunjuBPharm, MRes, PhDVideo26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025New Models for Drug Exposure and Safety During Pregnancy - Adeniyi OlagunjuView Video
STSteve TaylorMBChB, FRCP, PhDVideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025HIV PEP in Clinical Practice: Guidelines and Real-World Complexities - Steve TaylorView Video
VideoCOVID-1926th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #2 GS-443902 Concentrations in Peripheral Blood Mononuclear Cells and Dried Blood Spots among Pregnant and Non-Pregnant Women Receiving Remdesivir for COVID-19 Treatment - Alexandra DunbarView Video
VideoNTD26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #1 Population Pharmacokinetics of Tecovirimat in Persons with Mpox: Initial Results from ACTG A5418 - David NerguizianView Video
TJTom JacobsPharmD, PhDVideo26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025North-South Collaborations in Clinical Pharmacology Research - Tom JacobsView Video
VideoHIV26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Abstract #18 Antiviral Activity, Safety, and PK/PD of ACC017 in Antiretroviral Naïve HIV-Infected Adults: A Randomized, Double-Blind, Placebo/Dose-Parallel-Controlled Short-Term Monotherapy Study - Hong QinView Video
AMPLVideo26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025Session 4: The Silent Windmill - Uncovering the Impact of Cytomegolovirus (CMV)View Video
